It is a healthcare private limited company based in Kalyan, Maharashtra, India, established in 2012.
2012 | Kalyan, Maharashtra, India | Struck OffSterling Cancer & Diabetic Institute & Research Center Private Limited, a struck off private limited company, was established on 10 October 2012 in Kalyan, Maharashtra, India. Engaging in hospitals within the healthcare sector, it holds CIN: U85100MH2012PTC236663. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.10 M.
Its leadership includes Abrar Haroon Khan (Director), Umesh Devanand Warghat (Additional Director), Nagesh Bhuneshwar Mourya (Director). Past directors included Ajay Singh, Babu Kamal Satairam Saroj. It holds no open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at 1/Kalpraj Co-Operative Society Ltd., Bailbazar, Kalyan (West),, Kalyan, Maharashtra, 421301.
U85100MH2012PTC236663
236663
10 October 2012
₹1.00 Cr
₹0.10 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Sterling Cancer & Diabetic Institute & Research Center Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abrar Haroon Khan | Director | 10 Oct 2012 | Current |
| Umesh Devanand Warghat | Additional Director | 17 Aug 2013 | Current |
| Nagesh Bhuneshwar Mourya | Director | 10 Oct 2012 | Current |
| Lalita Yoganand Patil | Additional Director | 17 Aug 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jan 2013 | Past |
| Pramod Abcsdd | Additional Director | 22 Jun 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sterling Cancer & Diabetic Institute & Research Center's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sterling Cancer & Diabetic Institute & Research Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹9,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2013 | Punjab National Bank | ₹9.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sterling Cancer & Diabetic Institute & Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sterling Cancer & Diabetic Institute & Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterling Cancer & Diabetic Institute & Research Center's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 27 Feb 2013 via Charge ID 10411626 with Punjab National Bank was fully satisfied on 20 Mar 2017. was completed.
Progress on Sterling Cancer & Diabetic Institute & Research Center Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.
The activity Umesh Devanand Warghat was appointed as a Additional Director was appointed as a Additional Director on 17 Aug 2013 & has been associated with this company since 12 years 3 months . was completed.
Lalita Yoganand Patil was appointed as a Additional Director was appointed as a Additional Director on 17 Aug 2013 & has been associated with this company since 12 years 3 months . was recorded as a recent event.
Progress on Sterling Cancer & Diabetic Institute & Research Center Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was documented.
A charge with Punjab National Bank amounted to Rs. 0.95 Cr with Charge ID 10411626 was registered on 27 Feb 2013. was recorded as a recent event.
The CIN of Sterling Cancer & Diabetic Institute & Research Center Private Limited is U85100MH2012PTC236663.
Sterling Cancer & Diabetic Institute & Research Center Private Limited is headquartered at 1/Kalpraj Co-Operative Society Ltd., Bailbazar, Kalyan (West),, Kalyan, Maharashtra, 421301.
Sterling Cancer & Diabetic Institute & Research Center Private Limited was incorporated on 10 October 2012.
The current directors of Sterling Cancer & Diabetic Institute & Research Center Private Limited are
The primary industry of Sterling Cancer & Diabetic Institute & Research Center Private Limited is Healthcare.
Sterling Cancer & Diabetic Institute & Research Center Private Limited is unlisted.
The authorized capital of Sterling Cancer & Diabetic Institute & Research Center Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX